Cassava Sciences Debt 2024

Cassava Sciences Aktienanalyse

What does Cassava Sciences do?

Cassava Sciences Inc. is a biotechnology company founded in 1998. Its headquarters is in Austin, Texas. The company aims to research the inflammatory causes of neurodegenerative diseases, such as Alzheimer's, and develop new treatment options and medications. Cassava Sciences' business model is based on the development and commercialization of innovative therapies through research, clinical trials, and partnerships with other companies. The company focuses on developing treatment options for Alzheimer's disease. Cassava Sciences consists of various divisions that work closely together. One focus of the company is researching and developing new medications for the treatment of Alzheimer's. The company collaborates closely with scientists to develop new treatment options. Another important aspect of Cassava Sciences is conducting clinical trials to test the effectiveness and safety of the developed medications. The company collaborates with globally renowned research institutions. One of Cassava Sciences' products is the medication PTI-125, which was developed for the treatment of Alzheimer's. The medication aims to target the inflammatory causes of the disease and slow down its progression. PTI-125 is currently in Phase IIb of clinical testing and shows promising results. In recent years, Cassava Sciences has formed several partnerships with other companies to advance research and development of new treatment options. For example, the company collaborates with Pfizer and AbbVie. The history of Cassava Sciences is marked by intensive research activity and the goal of improving the quality of life for people with Alzheimer's disease. The company's research findings have been presented at scientific conferences and received significant media attention. In summary, Cassava Sciences is an innovative biotechnology company focused on researching and developing treatment options for Alzheimer's. In addition to developing new medications, the company also conducts clinical trials and collaborates with other companies to advance research. Cassava Sciences sees itself as a pioneer in the field of Alzheimer's therapy and aims to significantly improve the quality of life for people with this condition. Cassava Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Cassava Sciences's Debt Structure

Cassava Sciences's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Cassava Sciences's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Cassava Sciences’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Cassava Sciences’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Cassava Sciences stock

What is the debt of Cassava Sciences this year?

Cassava Sciences has a debt level of -121.14 USD this year.

What was the debt of Cassava Sciences compared to the previous year?

The debt of Cassava Sciences has increased by -39.73% compared to the previous year dropped.

What are the consequences of high debt for investors in Cassava Sciences?

High debt can pose a risk for investors of Cassava Sciences, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Cassava Sciences?

Low debt means that Cassava Sciences has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Cassava Sciences affect the company?

An increase in debt of Cassava Sciences can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Cassava Sciences affect the company?

A reduction in debt of Cassava Sciences can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Cassava Sciences?

Some factors that can influence the debt of Cassava Sciences include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Cassava Sciences so important for investors?

The debts of Cassava Sciences are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Cassava Sciences take to change the debt?

To change the debt, Cassava Sciences can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Cassava Sciences pay?

Over the past 12 months, Cassava Sciences paid a dividend of 5.25 USD . This corresponds to a dividend yield of about 181.66 %. For the coming 12 months, Cassava Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Cassava Sciences?

The current dividend yield of Cassava Sciences is 181.66 %.

When does Cassava Sciences pay dividends?

Cassava Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cassava Sciences?

Cassava Sciences paid dividends every year for the past 0 years.

What is the dividend of Cassava Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cassava Sciences located?

Cassava Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cassava Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cassava Sciences from 12/24/2012 amounting to 0.75 USD, you needed to have the stock in your portfolio before the ex-date on 12/13/2012.

When did Cassava Sciences pay the last dividend?

The last dividend was paid out on 12/24/2012.

What was the dividend of Cassava Sciences in the year 2023?

In the year 2023, Cassava Sciences distributed 0 USD as dividends.

In which currency does Cassava Sciences pay out the dividend?

The dividends of Cassava Sciences are distributed in USD.